FRC’s analysts will discuss the impact of Aphria and Tilray’s merger, potential for further consolidation in the space in 2021, and tips to pick M&A targets. Delta 9’s co-founder and CEO, John Arbuthnot, will talk about their latest product for decontamination and COVID-19 vaccine storage, and plans to ramp up retail footprint in 2021.
Head of Research
Sid Rajeev, FRC’s Head of Research, will discuss the impact of Aphria and Tilray’s merger, the potential for further consolidation in the space in 2021, and tips for picking M&A targets.
CEO of Delta 9 Cannabis Inc.
John Arbuthnot Delta 9’s Co-Founder and CEO will talk about their latest product for decontamination, COVID-19 vaccine storage, and plans to ramp up their retail footprint in 2021.